HMGB1 in Radiotherapy: A Two Headed Signal Regulating Tumor Radiosensitivity and Immunity

Radiotherapy (RT) is a mainstay of cancer treatment. Recent studies have shown that RT not only directly induces cell death but also has late and sustained immune effects. High mobility group box 1 (HMGB1) is a nuclear protein released during RT, with location-dependent functions. It is essential fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Liao, Yin, Liu, Shuya, Fu, Shaozhi, Wu, Jingbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7369309/
https://www.ncbi.nlm.nih.gov/pubmed/32764978
http://dx.doi.org/10.2147/OTT.S253772

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7369309/
https://www.ncbi.nlm.nih.gov/pubmed/32764978
http://dx.doi.org/10.2147/OTT.S253772

Ejemplares similares